Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 142
News
News | 22 February 2022

Dow, Sartorius and Südpack collaborate to support global supply of coronavirus vaccines

Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply

News
News | 21 February 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants

News
News | 21 February 2022

Sputnik Light gets a boost as China changes rules on boosters

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters

News
News | 21 February 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan

News
News | 21 February 2022

Corbevax receives EUA for 12-18 age group

It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19

News
News | 21 February 2022

SEBI approves IPO plans of PharmEasy and Wellness Forever Medicare

The companies plan to use the proceeds to retire debt and expand operations

News
News | 20 February 2022

Syncona completes sale of Gyroscope to Novartis

The transaction generates upfront cash proceeds of $442 million for Syncona's holding in Gyroscope

News
News | 20 February 2022

GSK pauses phase III RSV maternal vaccine candidate programme

This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.

News
News | 20 February 2022

USFDA lifts clinical hold on submission of Covaxin

Covaxin is a whole-virion inactivated Covid-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades

News
News | 20 February 2022

Hinduja Global Solutions bags contract from the UK Health Security Agency to provide critical services

The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.

News
News | 19 February 2022

Aizon’s CEO John Vitalie named one of the top 25 Biotech CEOs of 2022

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector

News
News | 19 February 2022

Fitch revises outlook on Jubilant Pharma to negative; affirms at 'BB'

Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).

News
News | 19 February 2022

Jagsonpal Pharma inks agreement with Suvinys Developers

Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.

News
News | 19 February 2022

Piramal Pharma appoints Amyra Dastur as brand ambassador for lacto calamine range

The brand has added a range of exciting new products especially formulated for oily skin.

News
News | 19 February 2022

Hetero’s molnupiravir Phase III studies show 65 % reduction in hospitalisation

Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the antiviral drug. There were no fatalities reported during the study

News
News | 19 February 2022

Indian pharma industry needs a winning partnership

The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines

News
News | 19 February 2022

Natco Q3FY22 PAT up 27% to Rs 80 Cr

The company registered consolidated total revenue of Rs 590.70 crore for Q3FY22.

News
News | 19 February 2022

UAE to recognise Indian pharma products within three months

The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.

News
News | 19 February 2022

Arrowhead Pharmaceuticals initiates study of ARO-C3

AROC3-1001 is a phase 1/2, placebo controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-C3

News
News | 19 February 2022

Abbott recalls powder formula manufactured at Sturgis, Mich., plant

Recall does not include any metabolic deficiency nutrition formulas

Startup

Digitization